Shenzhen Hingmed Medical Instrument Co., Ltd-About Hingmed

中文

Home page

All Categories>

Social Responsibility

Company Profile

Shenzhen Hingmed Medical Instrument Co., Ltd., referred to as "Hingmed Medical", was founded in 2014. It is a national high-tech enterprise engaged in the research and development and production of medical devices. It focuses on blood pressure monitoring and breathing technology and products, and is committed to providing advanced Blood pressure monitoring and breathing technology and products to make people healthier.

Hingmed Medical has always adhered to the concept of improving user experience through technological innovation. It has been widely recognized in the field of blood pressure and respiratory medical devices, and its ambulatory blood pressure monitors and other products for clinical application have been widely recognized. It has passed the clinical verification of the European Hypertension Society (ESH) and obtained UKCA certification in the UK, and has become a recommended product of the European Hypertension Society, the British Hypertension Society (BIHS) and the Chinese Hypertension Prevention Guidelines.

Development process

2014

In January, the company was established and obtained the production license of Class II medical devices in that year.

2015

In January, ABP series ambulatory blood pressure monitor went on sale
In July, the WBP series of ambulatory blood pressure monitors went on sale.
In August, the company obtained the ISO13485 quality system certification, ABP, WBP series dynamic blood pressure monitor through CE certification.

2016

In November, obtained the "national high-tech enterprise" certification

2017

In April, WBP-02A ambulatory blood pressure monitor successfully entered the French market

2018

In March, the WBP-02A ambulatory blood pressure monitor passed the clinical verification of the European Society of Hypertension (ESH) and became the recommended product of the European Society of Hypertension.

2019

In September, WBP-02A ambulatory blood pressure detector successfully entered the Italian market, used in telemedicine

2020

In August, reached a strategic cooperation with the School of Biomedical Engineering of Shenzhen University
December, DBP-01P medical automatic electronic sphygmomanometer listed

2021

In March, DBP-01P medical automatic electronic sphygmomanometer successfully entered the Thai market, serving more than 50 public and private hospitals in Thailand.
In May, participating in the United Nations aid to Africa project, DBP-01P medical automatic electronic sphygmomanometer began to serve major public hospitals in Ethiopia.
August, access to the State Intellectual Property Office approach anti-interference blood pressure algorithm invention patent
In September, DBP series of medical automatic electronic sphygmomanometers and ABP and WBP series of ambulatory blood pressure monitors made great breakthroughs in the Southeast Asian market and gained market recognition.
In November, WBP-02A ambulatory blood pressure monitor was certified by UKCA in the UK and became a BIHS (British Hypertension Society) recommended product.

2022

In June, it reached a strategic cooperation with Jingdong and entered Jingdong's own business.
In November, Q06, V03, V03D tracheeless series home electronic sphygmomanometers went on sale
In November, DBP-01P passed the clinical verification of ISO 81060-22018 international standard and became the recommended product of ESH (European Hypertension Society)
In December, the European market was further explored. DBP series of medical automatic electronic sphygmomanometers, ABP and WBP series of ambulatory blood pressure monitors and other products were exported to Britain, Italy, Spain and other countries.
In December, the company focused on technology research and development. Over the years, it has obtained 13 software copyrights, 24 patents including invention patents, and a number of patents are under application.

Core Competence

Shenzhen Xingmai Medical Instrument Co., Ltd.

Partners

Honor qualification

Enterprise culture